AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Aug 17, 2018
30071_dirs_2018-08-17_5cba954c-36d4-4650-95e6-ffc074803559.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-08-15
Reporting Person: McHale Richard (President, RC Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-15 | ResMed Common Stock | A | 7296 | — | Acquired | 19642 | Direct |
Footnotes
F1: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on August 15, 2018, when the compensation committee certified that the performance metrics were met.
F2: Includes 142.65 shares of ResMed stock purchased on April 30,2018, through the ResMed Employee Stock Purchase Plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29